Coronavirus Update: Rapid Restart For AZ’s Vaccine Trial, Pfizer Upsizes Its Phase III

UK Regulator Gives Green Light

Clearance by UK regulator allows trial to restart, with pivotal US trial hoped to follow suit to keep AstraZeneca and Oxford's candidate on track for a potential late 2020 readout. Plus, new results with Sinovac's vaccine in the elderly and progress with antibodies.  

Covid19_Carpark
The UK regulator's clearance has allowed the trial to restart, its counterparts in the US, South Africa and Brazil expected to follow suit. • Source: Shutterstock

More from COVID-19

More from Scrip